Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Rezolute, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Research and development
12.1
17.3
19.1
14.5
15
32.5
43.8
55.7
61.5
53.8
General and administrative
8.23
9.1
6.87
6.07
7.91
9.36
12.2
14.7
18.4
29.2
Operating expenses
20.3
28.7
25.9
20.5
22.9
41.8
56
70.4
79.9
83
Operating income
-20.3
-28.7
-25.9
-20.5
-22.9
-41.8
-56
-70.4
-79.9
-83
Interest expense
0
0.69
4.96
0
0.38
Interest income
0
0
Other non-operating income
0.05
-1.13
-4.5
0.19
1.99
0.78
4.2
1.96
5.48
Income tax
0
0
0
0
0
0
0
0
0
0
Net income to minority interests
0
2.27
Net income
-20.3
-29.9
-30.4
-20.3
-20.9
-41.1
-51.8
-68.5
-74.4
-77.6
EBITDA
-19.2
-27.7
-25.9
-20.5
-22.9
-41.8
-56
-70.4
-79.9
-82.9
EPS, basic
-28.36
-26.87
-18.41
-3.54
-2.72
-2.26
-1.01
-1.33
-0.98
-0.75
EPS, diluted
-28.36
-26.87
-18.41
-3.54
-2.72
-2.32
-1.01
-1.33
-0.98
-0.75
Shares, basic (weighted)
0.83
0
0
0.01
7.67
18.2
51.2
51.5
76
104
Shares, diluted (weighted)
0.83
0
0
0.01
7.67
19.5
51.2
51.5
76
104
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Cash and equivalents
4.49
1.65
37.6
77.4
41
150
16
70.4
94.1
10.6
Short-term investments
85.9
56.5
73.8
97.2
Other current assets
0.44
0.36
0.57
0.56
0.95
1.69
3.01
1.78
3.29
2.71
Total current assets
4.93
2.01
12.1
10.5
42
152
105
129
171
111
Property, plant and equipment
5.33
0.37
0.04
0.03
0.03
0.02
0.14
0.1
0.07
0.04
Lease right-of-use assets
0
0.38
0.4
0.15
2.05
1.88
1.35
0.77
Intangible assets
0.04
0.04
0.03
0
Long-term investments
16.5
0.26
Total assets
10.6
2.5
12.3
11
42.6
152
124
133
175
113
Accounts payable
0.95
1.85
0.56
0.89
1.04
1.13
3.27
4.9
5.81
5.03
Accrued liabilities
0.79
0.12
0.08
0.88
1.81
2.27
2.04
Total current liabilities
1.77
6.25
8.38
3.23
1.97
2.46
5.2
9.61
11.9
11.4
Lease liabilities
0
0.17
0.19
0.08
1.94
1.66
0.98
0.28
Other non-current liabilities
0.3
0.22
0.12
0
Total liabilities
2.1
6.46
10.5
3.6
16.5
2.95
7.55
11.7
13.4
12.2
Total debt
3.43
0
0
14
Paid-in capital
72.8
90.2
129
155
194
359
377
450
566
582
Retained earnings
-64.3
-94.2
-127
-147
-168
-209
-261
-329
-404
-481
Other comprehensive income
-0.35
-0.08
-0.01
-0.12
Shareholders' equity
8.53
-3.96
1.75
7.37
26.1
149
116
121
162
101
Total equity
8.53
-3.96
1.75
7.37
26.1
149
116
121
162
101
Total liabilities and equity
10.6
2.5
12.3
11
42.6
152
124
133
175
113
Shares outstanding
0.99
0
4.21
5.87
8.35
33.6
36.8
53.2
87
96.4
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
FY2026
Net income
-20.3
-29.9
-30.4
-20.3
-20.9
-41.1
-51.8
-68.5
-74.4
-77.6
Depreciation and amortization
1.11
1.07
0.05
0.02
0.01
0.01
0.03
0.04
0.03
0.03
Stock-based compensation
6.01
5.1
2.64
3.32
3.97
3.69
7.27
7.36
7.12
14.5
Deferred income tax
0
Change in payables
-0.93
0.33
0.14
-0.01
2.14
1.08
1.42
-0.75
Cash from operations
-13.3
-14.1
-15.3
-24.2
-20.4
-39.6
-44.5
-57.4
-69.1
-64.6
Capital expenditures
-0.01
-0.05
0
-0.15
Purchases of investments
-107
-66.4
-128
-178
Sales and maturities of investments
0
115
114
157
Cash from investing
-0.2
1.73
0.23
0
0
-101
48.7
-14.5
-21.1
Debt repaid
-16
Stock issued
4.5
0
24.1
0
0.23
0.89
2.28
Share buybacks
-0
Cash from financing
13.9
9.54
25
22.6
51.5
149
11.6
63
107
2.24
Net change in cash
-2.84
9.93
-1.62
31.1
109
-134
54.4
23.7
-83.5
Free cash flow
-14.1
-15.4
-24.2
-44.6
Interest paid
0
0
0
0
0.18
1.49
Income taxes paid
0
0
0
0
0
Key metrics
Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $3.90 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Return on equity (ROE)
-59.0%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-53.8%
Net income / average total assets.
Return on invested capital (ROIC)
-82.9%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Growth
Metric
Value
How it is calculated
Book value growth, 1y
-37.9%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y
-4.7%
Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y
31.0%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-35.7%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-3.0%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
21.5%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
36.7%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
26.6%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
68.4%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
9.68x
Current assets / current liabilities.
Quick ratio
9.44x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
9.44x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
-$0.75
Net income per basic share, as reported (split-adjusted).
Operating cash flow per share
-$0.62
Cash from operations / diluted weighted shares.
Book value per share
$1.04
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/B
3.73x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
3.73x
Market cap / tangible book value, when positive.
Earnings yield
-20.7%
Net income / market cap (the inverse of P/E).
Was Rezolute, Inc. profitable in fiscal 2026?
No. It reported a net loss of $77.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.